SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001683168-19-003197
Filing Date
2019-10-07
Accepted
2019-10-08 07:47:37
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM S-1 AMENDMENT 3 cns_s1a3.htm S-1/A 1140431
2 EMPLOYMENT AGREEMENT BETWEEN CNS PHARMACEUTICALS, INC. AND CHRISTOPHER DOWNS DAT cns_ex1010.htm EX-10.10 62254
3 CONSENT OF MALONEBAILEY LLP cns_ex2301.htm EX-23.1 2494
4 GRAPHIC malonelogo.jpg GRAPHIC 6186
  Complete submission text file 0001683168-19-003197.txt   1214836
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-232443 | Film No.: 191141806
SIC: 2834 Pharmaceutical Preparations